ER Pharmatech Co.,LTD

Linagliptin

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione;1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;

• CAS NO :

  668270-12-0

• EC NO :

• Molecular Formula :

  C₂₅H₂₈N₈O₂

• Molecular Weight :

  472.5422

• Main Specifications :

  99%

• InChI :

  InChI=1/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1

• Packing :

  As customer request

• Product description :

  Product Name: Linagliptin Synonyms: Tradjenta;Linagliptin-D4;Linagliptin (BI-1356);Linaglitine;(R)-8-(3-aMinopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-1H-purine-2,6(3H,7H)-dione;Linagliptin API CAS: 668270-12-0 MF: C25H28N8O2 MW: 472.54 EINECS: 1308068-626-2 Melting point 202 ºC density 1.39 Uses: 1.A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. 2.dipeptidypeptidase inhibitor, antidiabetic 3.highly potent CD26 inhibitor 4.Labeled Linagliptin, intended for use as an internal standard for the quantification of Linagliptin by GC- or LC-mass spectrometry.

• Uses :

  A novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.

• Molecular Structure :